Berkeley HeartLab provides a third-generation technology and complete suite of tests designed to assist a physician in developing a comprehensive patient baseline for ongoing patient monitoring.

Berkeley’s industry leading s-GGE products indicates the percentage of small dense atherogenic LDL particles and the percentage of mature cardioprotective HDL particles.

Berkeley HeartLab recently launched a new monitoring metric, Atherogenic Subclass Quantitation.

Extensive literature supports the Berkeley HeartLab approach to assessing and managing the underlying causes of coronary heart disease. To access the lists of pertinent publications, please click here.